Moderna, the US-based biotech company working on developing a Covid-19 vaccine, saw its shares soar by more than 13 percent Tuesday after announcing promising results from its Phase 1 trial.
The Cambridge, Massachusetts startup revealed its early-stage tests produced strong immune responses and was generally safe.
U.S. Correspondent Liling Tan reports.
IN: "Moderna said its….
OUT: SOC
DUR: 40 seconds